샘플 요청 목록

 카트 문의
시장보고서
상품코드
1571685

북미의 재택의료 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 적응증별, 지역별, 부문별 예측(2024-2030년)

North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 80 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

북미의 재택의료 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 북미의 재택의료 시장 규모는 2024년부터 2030년까지 연평균 7.7%의 성장률을 기록하여 2030년에는 2,850억 5,000만 달러에 달할 것으로 예상됩니다.

고령화 인구의 증가, 의료비 지출에 대한 가처분 소득 증가, 대상 질환의 증가율 등이 성장을 촉진하는 주요 요인입니다. 만성질환의 우위, 진단 비용의 증가가 성장을 견인할 것으로 예상됩니다.

개별화된 의료 지원은 치료 비용을 억제하는 비용 효율적인 수단으로 업계의 주요 원동력으로 작용할 것입니다. 미국 건강 순위에 따르면 2022년에는 미국에 거주하는 65세 이상 성인이 약 5,800만 명에 달할 것으로 예상됩니다.

재택의료 산업은 정맥 정체성 궤양, 당뇨성 궤양, 욕창 등 다양한 질병에 걸리기 쉬운 고령화 인구의 증가로 인해 크게 성장할 것으로 예상되며, WHO에 따르면 전 세계 60세 이상 인구는 2014년 8억 4,100만 명에 달하고 2050년에는 20억 명에 달할 것으로 예상됩니다. 따라서 전 세계 고령화율의 증가와 재택의료 환자의 약 70%가 65세 이상 연령층에 속한다는 통계는 가까운 장래에 수요를 촉진할 것으로 예상됩니다.

상처 치료는 2014년 세계 시장 매출의 65%를 차지했습니다. 지난 몇 년간 상처 봉합재, 상처 드레싱 및 상처 세척제에 대한 높은 수요로 인해 이 분야는 지난 몇 년 동안 우위를 점해왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다. 상처 감염은 의료진과 환자들에게 중요한 안전 문제이기 때문에 감염률을 낮추기 위해 시장 수요를 촉진할 것으로 예상됩니다. 상처 관리 제품은 당뇨병성 궤양, 욕창, 정맥 정체성 궤양과 같은 다양한 질환을 앓고 있는 환자의 전반적인 건강을 개선하기 때문에 업계는 이러한 제품에 대한 강력한 수요를 창출하고 있습니다.

개인 안전과 위생에 대한 인식이 높아짐에 따라 노인 환자의 증가는 북미의 재택의료 서비스에 대한 수요를 더욱 증가시킬 것으로 예상됩니다. Baxter는 의료 전문가에게 개인별 맞춤 치료를 제공하기 위한 다양한 솔루션을 제공하고 있습니다. 병원 치료, 일차 치료, 신장 치료, 수술 치료, 영양 치료 등 의료 전문가를 위한 제품을 제공하고 있습니다.

2023년 시장 점유율은 서비스 분야가 84.1%로 가장 컸습니다. 이 부문은 다시 숙련된 재택 간호와 비숙련된 재택 간호로 나뉩니다. 재택의료 서비스에는 영양 지원, 간호, 호스피스 및 완화 치료, 의사에 의한 일차 진료 등 다양한 서비스가 제공됩니다. 숙련된 의료진이 제공하는 정확한 진단과 치료가 이 부문의 성장에 기여하고 있습니다. 한편, 기기 부문은 예측 기간 동안 8.6%의 CAGR을 기록할 것으로 예상됩니다. 이 부문은 치료, 진단 및 이동 보조 장치 부문으로 나뉩니다.

미국 재택의료 시장은 높은 수준의 의료 인프라를 바탕으로 2023년 90.0%의 점유율로 북미 시장을 장악했습니다. 고령화 인구가 많고, 헬스케어 인프라가 잘 갖춰져 있으며, 구매력이 높은 것이 성장을 촉진하는 주요 요인으로 꼽힙니다. 또한, 재택간호 서비스를 장려하여 치료비 절감을 위한 정부 이니셔티브가 성장을 촉진할 것으로 예상됩니다. 인구문제연구소(PRB)에 따르면, 북미의 65세 이상 인구는 현재 약 5,000만 명이며, 2050년에는 8,900만 명에 달할 것으로 예측됩니다.

북미의 재택의료 시장 보고서 하이라이트

  • 2023년 시장 점유율은 서비스 분야가 84.1%로 가장 큽니다. 이 부문은 다시 숙련된 재택 간호와 비숙련된 재택 간호로 나뉩니다.
  • 기기 부문은 예측 기간 동안 8.6%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 이 부문은 치료, 진단 및 이동 지원 부문으로 나뉩니다.
  • 2023년에는 당뇨병 및 신장 질환 분야가 가장 큰 시장 점유율을 차지했습니다. 미국 당뇨병 협회에 따르면 2021년 미국인 3,840만 명이 당뇨병 진단을 받았습니다.
  • 이동 장애 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 북미의 재택의료 시장 변수, 동향, 범위

  • 시장 소개/계통 전망
  • 시장 규모와 성장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 북미의 재택의료 시장 분석 툴
    • Porters 분석
    • PESTEL 분석

제4장 북미의 재택의료 시장 : 구성요소 추정·동향 분석

  • 부문 대시보드
  • 북미의 재택의료 시장 : 구성요소 변동 분석, 2023년 및 2030년
  • 장비
  • 서비스

제5장 북미의 재택의료 시장 : 적응증 추정·동향 분석

  • 부문 대시보드
  • 북미의 재택의료 시장 : 적응증 변동 분석, 2023년 및 2030년
  • 심혈관질환과 고혈압
  • 당뇨병과 신장질환
  • 신경질환 및 정신질환
  • 호흡기질환과 COPD
  • 산모 질환
  • 운동장애
  • 암
  • 창상관리
  • 기타

제6장 북미의 재택의료 시장 : 지역 추정·동향 분석

  • 북미의 재택의료 시장 점유율, 지역별, 2023년 및 2030년
  • 북미
    • 미국
    • 캐나다
    • 멕시코

제7장 경쟁 상황

  • 주요 시장 진출 기업의 최근 동향과 영향 분석
  • 기업 분류
  • 기업 히트맵 분석
  • 기업 개요
    • B. Braun SE
    • Abbott
    • Sunrise Medical
    • 3M
    • Baxter
    • Medtronic
    • Cardinal Health
    • F. Hoffmann-La Roche Ltd
    • Amedisys
    • ARKRAY, Inc.
    • BD
    • OMRON Healthcare, Inc.
    • GE Healthcare
    • Medline Industries, Inc
    • Koninklijke Philips NV
    • Johnson & Johnson Services, Inc.
    • Acelity(3 M)
    • Teleflex Incorporated.
    • Fresenius Kabi AG.
    • Bayer AG
    • GF Health Products, Inc.
    • Knight Health Holdings, LLC
    • NHC, National Healthcare Corporation
    • Gentiva
    • Medco Home Healthcare, Inc.
    • Brookdale Senior Living Inc.
    • Sunrise Senior Living
    • Genesis HealthCare
    • EXTENDICARE.
    • Diversicare.
    • Home Instead, Inc.
    • Senior Services of America
    • Atria Senior Living, Inc
ksm 24.11.01

North America Home Healthcare Market Growth & Trends:

The North America home healthcare market size is expected to reach USD 285.05 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising aging human population, high disposable income for healthcare expenditure, and increasing rate of target diseases are some of the key factors driving growth. Predominance of chronic diseases, and increasing diagnosis expenditure is anticipated to boost growth.

Personalized medical assistance is a cost effective measure to control treatment expenditure and acts as a major driver for the industry. According to America's Health rankings, nearly 58 million adults aged 65 and older lived in the U.S. in 2022.

The home healthcare industry is anticipated to be majorly driven by the huge aging population volume which is highly prone to various diseases such as venous stasis ulcers, diabetic ulcers, and pressure ulcers. According to WHO, the global volume of population falls under the age group of 60 years and above has reached 841 million in 2014 and is expected to reach 2 billion by 2050. Therefore, rising global aging-population along with the statistics that approximately 70% of home healthcare patients belong to 65 years and above age group, is anticipated to fuel demand in the near future.

Wound care accounted for 65% of the global market revenue in 2014. Substantial demand for wound closures, wound care dressings, and wound cleanser has resulted in the dominance of the segment over the past few years and this trend is expected to continue over the forecast period. Wound infection is a key safety concern for medical professionals and patients, thus the market is anticipated to fuel the demand as it compelled to reduce the infection rates. Wound care products improve the overall health of patients affected from various disorders such as, diabetic ulcers, pressure ulcers and venous stasis ulcers, therefore creating strong need for these products in the industry.

Rising number of geriatric patients with growing awareness about personal safety and hygiene is further expected to intensify home healthcare service demand in North America. Baxter offers broad solutions to empower healthcare professionals to offer personalized care. It offers products for healthcare professionals for hospital care, primary care, kidney care, surgical care, nutritional care and others.

The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare. Different services such as nutritional support, nursing care, hospice & palliative, physician primary care, and others are offered by home healthcare services. The accurate diagnosis and medical treatment offered by skilled healthcare is attributing the segment growth. On the other hand, the equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.

The U.S. home healthcare market dominated the North America market with a share of 90.0% in 2023 due to advanced healthcare infrastructure. Large base of aging population, growing healthcare infrastructure and high purchasing power are some of the key factors driving growth. Moreover, favorable government initiatives aimed at controlling treatment expenditure by promoting home care services are anticipated to fuel growth. According to the PRB (Population Reference Bureau), at present, approximately 50 million citizens of North America are over 65 years and the number is projected to reach 89 million by 2050.

North America Home Healthcare Market Report Highlights:

  • The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare.
  • The equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.
  • The diabetes & kidney disorders segment accounted for the largest market share in 2023. According to American Diabetes Association, 38.4 million Americans were diagnosed with diabetes in 2021.
  • The mobility disorders segment is projected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Home Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America Home Healthcare Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America Home Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Therapeutic
      • 4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Home Respiratory Equipment
          • 4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.2. Insulin Delivery Market
          • 4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.3. Home IV Pumps
          • 4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.4. Home Dialysis Equipment
          • 4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.5. Other Therapeutic Equipment
          • 4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Diagnostic
      • 4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.1. Diabetic Care Unit
          • 4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.2. BP Monitors
          • 4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.3. Multi Para Diagnostic Monitors
          • 4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.4. Home Pregnancy and Fertility Kits
          • 4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.5. Apnea and Sleep Monitors
          • 4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.6. Holter Monitors
          • 4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.7. Heart Rate Meters (include pacemakers)
          • 4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.8. Others
          • 4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Mobility Assist
      • 4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.1. Wheel Chair
          • 4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.2. Home Medical Furniture
          • 4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.3. Walking Assist Devices
          • 4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Skilled Home Healthcare
      • 4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.1. Physician Primary Care
          • 4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.2. Nursing Care
          • 4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.3. Physical/Occupational/Speech Therapy
          • 4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.4. Nutritional Support
          • 4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.5. Hospice & Palliative
          • 4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.6. Other Skilled Nursing Services
          • 4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unskilled Home Healthcare
      • 4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Home Healthcare Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Disorder & Hypertension
    • 5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diabetes & Kidney Disorders
    • 5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurological & Mental Disorders
    • 5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Respiratory Diseases & COPD
    • 5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Maternal Disorders
    • 5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Mobility Disorders
    • 5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Cancer
    • 5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Wound Care
    • 5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Home Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Abbott
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Sunrise Medical
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. 3M
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Baxter
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cardinal Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. F. Hoffmann-La Roche Ltd
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Amedisys
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. ARKRAY, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. BD
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. OMRON Healthcare, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. GE Healthcare
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Medline Industries, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Koninklijke Philips N.V.
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Johnson & Johnson Services, Inc.
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
    • 7.4.17. Acelity (3M)
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/ Strategic Initiatives
    • 7.4.18. Teleflex Incorporated.
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/ Strategic Initiatives
    • 7.4.19. Fresenius Kabi AG.
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/ Strategic Initiatives
    • 7.4.20. Bayer AG
      • 7.4.20.1. Participant's Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Recent Developments/ Strategic Initiatives
    • 7.4.21. GF Health Products, Inc.
      • 7.4.21.1. Participant's Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Recent Developments/ Strategic Initiatives
    • 7.4.22. Knight Health Holdings, LLC
      • 7.4.22.1. Participant's Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Recent Developments/ Strategic Initiatives
    • 7.4.23. NHC, National Healthcare Corporation
      • 7.4.23.1. Participant's Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Recent Developments/ Strategic Initiatives
    • 7.4.24. Gentiva
      • 7.4.24.1. Participant's Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Recent Developments/ Strategic Initiatives
    • 7.4.25. Medco Home Healthcare, Inc.
      • 7.4.25.1. Participant's Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Recent Developments/ Strategic Initiatives
    • 7.4.26. Brookdale Senior Living Inc.
      • 7.4.26.1. Participant's Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Recent Developments/ Strategic Initiatives
    • 7.4.27. Sunrise Senior Living
      • 7.4.27.1. Participant's Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Recent Developments/ Strategic Initiatives
    • 7.4.28. Genesis HealthCare
      • 7.4.28.1. Participant's Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Recent Developments/ Strategic Initiatives
    • 7.4.29. EXTENDICARE.
      • 7.4.29.1. Participant's Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Recent Developments/ Strategic Initiatives
    • 7.4.30. Diversicare.
      • 7.4.30.1. Participant's Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Recent Developments/ Strategic Initiatives
    • 7.4.31. Home Instead, Inc.
      • 7.4.31.1. Participant's Overview
      • 7.4.31.2. Financial Performance
      • 7.4.31.3. Product Benchmarking
      • 7.4.31.4. Recent Developments/ Strategic Initiatives
    • 7.4.32. Senior Services of America
      • 7.4.32.1. Participant's Overview
      • 7.4.32.2. Financial Performance
      • 7.4.32.3. Product Benchmarking
      • 7.4.32.4. Recent Developments/ Strategic Initiatives
    • 7.4.33. Atria Senior Living, Inc
      • 7.4.33.1. Participant's Overview
      • 7.4.33.2. Financial Performance
      • 7.4.33.3. Product Benchmarking
      • 7.4.33.4. Recent Developments/ Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제